Sublethal Concentrations of Prion Peptide PrP106–126 or the Amyloid Beta Peptide of Alzheimer's Disease Activates Expression of Proapoptotic Markers in Primary Cortical Neurons

This publication has 57 references indexed in Scilit:

• Prion Protein-Deficient Neurons Reveal Lower Glutathione Reductase Activity and Increased Susceptibility to Hydrogen Peroxide Toxicity
  The American Journal of Pathology, 1999
• Neuronal Apoptosis Induced by β-Amyloid Is Mediated by Caspase-8
  Neurobiology of Disease, 1999
• Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
  The American Journal of Pathology, 1999
• Changes in Caspase Expression in Alzheimer's Disease: Comparison with Development and Aging
  Biochemical and Biophysical Research Communications, 1999
• Amyloid β-peptide induces apoptosis-related events in synapses and dendrites
  Brain Research, 1998
• Caspases: killer proteases
  Trends in Biochemical Sciences, 1997
• PrP and β-Amyloid Fragments Activate Different Neurotoxic Mechanisms in Cultured Mouse Cells
  European Journal of Neuroscience, 1997
• Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl.
  The Journal of Experimental Medicine, 1995
• Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment
  NeuroReport, 1994
• Neurotoxicity of a prion protein fragment
  Nature, 1993